Skip to content

Clinical trials

Gram-Positive Bacterial Infections trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gram-Positive Bacterial Infections Country / region: United States Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20032
20041
20052
20061
20082
20091
20101
20142
20172
20182
20191
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)4
Cumberland Pharmaceuticals4
Pfizer3
Biomedical Advanced Research and Development Authority1
Forest Laboratories1
Mannkind Corporation1
Melinta Therapeutics, Inc.1
Melinta Therapeutics, LLC1
MicuRx1
NICHD Neonatal Research Network1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gram-Positive Bacterial Infections22
Bacterial Infections4
Abscess3
Bacteremia3
Cellulitis3
Wound Infection3
Burns2
Endocarditis2
Gram-Negative Bacterial Infections2
Sepsis2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.